MedTrace Logo

Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion

NCT02010827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-12-02

No results posted yet for this study

Summary

We want to investigate how lack of glucagon suppression during an oral glucose tolerance test in patients with type 2 diabetes contributes to patients postprandial hyperglycemia.

Conditions

Interventions

BIOLOGICAL

isoglycemic intravenous glucose infusion and Glucagon infusion, day C

Infusion of 0.8ng/kg/min glucagon from time 0-25min

BIOLOGICAL

Oral glucose tolerance test, day A

BIOLOGICAL

intravenous iv glucose infusion, day B

Sponsors & Collaborators

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-09-30
Completion
2015-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02010827 on ClinicalTrials.gov